2016
DOI: 10.1016/j.archger.2016.04.001
|View full text |Cite
|
Sign up to set email alerts
|

Oral Candida isolates and fluconazole susceptibility patterns in older Mexican women

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

2
14
0

Year Published

2016
2016
2024
2024

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 17 publications
(19 citation statements)
references
References 33 publications
2
14
0
Order By: Relevance
“…Voriconazole can be used as step-down treatment of C. glabrata or C. krusei infections (if susceptibility results suggest that they are active) or if additional mould coverage is required [2,3]. In the elderly, colonisation and infections with non-albicans species, including C. glabrata, has been shown to be increased [6,33,34]. In recent studies, the susceptibility to fluconazole and voriconazole of non-albicans species isolated from the elderly was approximately doubled when compared with the susceptibility of isolates obtained from younger patients [6,7,35].…”
Section: Azolesmentioning
confidence: 99%
“…Voriconazole can be used as step-down treatment of C. glabrata or C. krusei infections (if susceptibility results suggest that they are active) or if additional mould coverage is required [2,3]. In the elderly, colonisation and infections with non-albicans species, including C. glabrata, has been shown to be increased [6,33,34]. In recent studies, the susceptibility to fluconazole and voriconazole of non-albicans species isolated from the elderly was approximately doubled when compared with the susceptibility of isolates obtained from younger patients [6,7,35].…”
Section: Azolesmentioning
confidence: 99%
“…Voriconazole can be used as step-down treatment of C. glabrata or C. krusei infections (if susceptibility results suggest that they are active) or if additional mould coverage is required [ 2 , 3 ]. In the elderly, colonisation and infections with non- albicans species, including C. glabrata , has been shown to be increased [ 6 , 33 , 34 ]. In recent studies, the susceptibility to fluconazole and voriconazole of non- albicans species isolated from the elderly was approximately doubled when compared with the susceptibility of isolates obtained from younger patients [ 6 , 7 , 35 ].…”
Section: Antifungal Treatment In the Elderlymentioning
confidence: 99%
“…Over the last ten years, some studies have found an increase in the Non-Albicans Candida (NAC) recovery frequency in oral mucosa: from 10 % in 1996 [15] to 15.0% [16] in 2010, 15.4 % in 2011 [17], and 20.0% in 2017 [35] in the case of C. parapsilosis at the level of healthy subjects. Among the local and/or systemic factors associated with the higher distribution of NAC species in the oral cavity, we could mention the use of prosthetic devices; [64] being elderly [65], elderly with low body mass index [66]; being an oncological patient undergoing chemotherapy or radiotherapy…”
Section: Oral Mucosa As a Potential Source Of Candidemia By Candida Pmentioning
confidence: 99%
“…Reports have indicated that C. parapsilosis and C. dubliniensis are the Candida species most frequently detected in oral niches after C. albicans among immune competent subjects [16,17,35,65,72,73]. Nevertheless, the epidemiology and behavior of the C. parapsilosis complex given different conditions of the oral cavity are still unknown.…”
Section: Oral Mucosa As a Potential Source Of Candidemia By Candida Pmentioning
confidence: 99%